Cargando…
Bmi1, medulloblastoma and regenerative therapy
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529326/ |
Ejemplares similares
-
Convergence of BMI1 and CHD7 on ERK Signaling in Medulloblastoma
por: Badodi, Sara, et al.
Publicado: (2017) -
Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma
por: Badodi, Sara, et al.
Publicado: (2022) -
EMBR-22. RATIONAL DEVELOPMENT OF SYNERGISTIC THERAPIES ALONGSIDE BMI1 INHIBITION FOR GROUP 3 MEDULLOBLASTOMA
por: Bakhshinyan, David, et al.
Publicado: (2021) -
Regeneration Roadmap: database resources for regenerative biology
por: Kang, Wang, et al.
Publicado: (2021) -
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial design
por: Bartunek, Jozef, et al.
Publicado: (2015)